Key facts
- Oura said the deal is all cash and values Counsel Health at $625 million.
- Counsel Health combines medical AI with in-house physicians, escalating chats to board-certified doctors, Oura said.
- Oura said more than 90% of surveyed members using Counsel said Oura data helped them get better care.
- Counsel Health had previously disclosed $36 million in funding, STAT reported.
- Oura chief executive Tom Hale said the combination aims to deliver a 24-7 doctor in your pocket.
Oura said on November 10, 2026 that it will buy Counsel Health, an AI-native primary care company, for $625 million in an all-cash deal. The smart ring maker said the two companies signed a definitive agreement.
Oura said the combination pairs its continuous biometric data with Counsel's platform and on-demand physicians. Members can start from an Oura insight or chat with Counsel's medical AI, and the conversation can escalate to a board-certified Counsel physician within minutes inside the Oura App, according to Oura.
Counsel Health combines medical AI with in-house physicians, and its service is available through enterprise partnerships including health plans, health systems, consumer health organizations and employers, Oura said. Oura said more than 90% of surveyed members using Counsel said their Oura data helped them get better care, and members who saw a Counsel physician rated their care experience 4.6 out of 5.
"Oura helps members understand their physiology and, with Counsel, they can take action on their health," Oura chief executive Tom Hale said in the statement. Counsel founder and chief executive Muthu Alagappan said the companies negotiated the deal over the past few months.
STAT reported that Counsel Health had previously disclosed $36 million in funding and that Oura delayed plans to go public just over a month before the announcement, citing market uncertainty.